⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight
globenewswire.com
VNDA
GRFS
BHC
RDHL
MRK
TEVA
PFE
SNY
LLY
ABBV
AZN
CRCT
SPRO
CRNX
Par Health Names Norv McAndrew as EVP, Chief Legal Officer and Corporate Secretary
prnewswire.com
TEVA
JNJ
PFE
PRPH
Eye Allergy Treatment Market to Surpass $5.97 Billion by 2031, Fueled by Increasing Eye Allergy Prevalence: Industry Research by The Insight Partners.
globenewswire.com
BHC
TEVA
Berman Tabacco, Sperling Kenny Nachwalter, LLC and Hilliard Shadowen LLP Announce a Class Action Settlement If You Purchased, Paid For, or Provided Reimbursement for QVAR® and/or QVAR RediHaler® Inhalers From January 1, 2015 through July 31, 2025
prnewswire.com
TEVA
Trastuzumab Biosimilars Market Analysis Report 2026: $24.48 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
AMGN
TEVA
Pharmaceutical API Manufacturing Market Research Report 2026: $347.49 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
SNY
TEVA
Analysis of the 2026 Oral Solid Dosage Contract Manufacturing Market - Scalable Pharma Solutions & Generic Demand Drive $59.05 Billion Forecast for 2030
globenewswire.com
JBL
TEVA
Teva's 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets
accessnewswire.com
TEVA
Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets
globenewswire.com
TEVA
Alcoholism Treatment Market Report 2026: Revenue to Reach $36.85 Billion in 2026, Growing by $2.27 Billion YoY
globenewswire.com
ADIL
ALKS
AZN
BCO
CATX
LLY
GSK
MRK
PFE
SNY
TEVA